Macular Edema and Macular Degeneration Market Report 2026
Download Free Sample Buy Now
Macular Edema and Macular Degeneration Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Macular Edema and Macular Degeneration Market Report 2026

Global Outlook – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration), By End User (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Macular Edema and Macular Degeneration Market Overview

• Macular Edema and Macular Degeneration market size has reached to $10.33 billion in 2025

• Expected to grow to $14.33 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%

• Growth Driver: Elevated Diabetes Prevalence Fuels Growth In The Macular Edema And Macular Degeneration Market

• Market Trend: Next-Generation Solutions for Chronic Eye Conditions Transforming Standard Care Practices

• North America was the largest region in 2025.

What Is Covered Under Macular Edema and Macular Degeneration Market?

Macular edema and macular degeneration are two different eye conditions that can affect vision. Macular edema is swelling in the part of the retina at the back of the eye, which can cause blurry vision. Macular degeneration is a condition that affects the macula, a part of the retina at the back of the eye that is responsible for central vision. They can be caused by many different conditions, including diabetic retinopathy, retinal vein occlusion, and inflammation, and include age, genetics, smoking, high blood pressure, and obesity.

The main types of macular edema and macular degeneration treatment include drug therapy and laser treatment. Drug therapy refers to the use of pharmaceutical drugs or medications to treat, manage, or alleviate medical conditions, diseases, or symptoms in individuals. It is used for various applications including macular edema, diabetic macular edema (DME), cystoid macular edema (CME), macular degeneration, dry age-related macular degeneration, and wet age-related macular degeneration by hospitals, clinics, and other end users.

Macular Edema and Macular Degeneration Market Global Report 2026 Market Report bar graph

What Is The Macular Edema and Macular Degeneration Market Size and Share 2026?

The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $10.33 billion in 2025 to $11.03 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing prevalence of diabetes and retinal disorders, aging population with higher vision impairment risk, clinical success of anti-vegf injections, growing awareness of macular diseases, expansion of ophthalmology clinics.

What Is The Macular Edema and Macular Degeneration Market Growth Forecast?

The macular edema and macular degeneration market size is expected to see strong growth in the next few years. It will grow to $14.33 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising global diabetic population, increasing screening for retinal diseases, growing demand for minimally invasive eye treatments, expanding access to advanced ophthalmic care, higher healthcare spending on vision preservation. Major trends in the forecast period include rising adoption of anti-vegf based therapies, growing demand for early diagnosis and intervention, increasing use of combination drug and laser therapies, rising focus on managing diabetic eye complications, expansion of outpatient and clinic-based eye care.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Macular Edema and Macular Degeneration Market Segmentation

1) By Treatment Type: Drug Therapy, Laser Treatment

2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Combination Therapy (Anti-VEGF + Steroids)

2) By Laser Treatment: Focal Laser Photocoagulation, Subthreshold Laser Therapy, MicroPulse Laser Therapy

What Is The Driver Of The Macular Edema and Macular Degeneration Market?

The rising diabetes population is expected to propel the growth of the macular edema and macular degeneration market going forward. Diabetes is a chronic medical condition characterized by high glucose (sugar) levels in the blood. Diabetes damages the blood vessels in the eye, which can result in macular edema and macular degeneration. For instance, in June 2024, according to The National Health Service (NHS England), a UK-based publicly funded healthcare system, in 2023, the number of individuals identified by the NHS in England as having pre-diabetes rose to 3,615,330, marking an 18% increase from 3,065,825 in 2022. Additionally, among those under 40, cases surged nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Therefore, the rising diabetes population is driving the growth of the macular edema and macular degeneration industry.

Key Players In The Global Macular Edema and Macular Degeneration Market

Major companies operating in the macular edema and macular degeneration market are F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, AbbVie Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co Ltd, Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Kodiak Sciences Inc., Opthea Limited, IVERIC bio Inc., Neurotech Pharmaceuticals Inc., Regenxbio Inc., Graybug Vision Inc., Clearside Biomedical Inc., Kubota Pharmaceutical Holdings Co Ltd, Acucela Inc., PanOptica Inc., Ocugen Inc.

Global Macular Edema and Macular Degeneration Market Trends and Insights

Major companies operating in the macular edema and macular degeneration market are focusing on developing innovative products such as continuous-delivery ocular implants to reduce treatment burden, improve patient adherence, and deliver more consistent long-term therapeutic outcomes. Continuous-delivery ocular implants are small, refillable devices placed in the eye that slowly release medication over several months, helping patients by reducing the need for frequent injections and providing steady, long-term treatment for retinal diseases. For instance, in February 2025, F. Hoffmann-La Roche Ltd, a Switzerland-based biotechnology company, received U.S. Food and Drug Administration (FDA) approval for Susvimo, a refillable ocular implant delivering the anti-VEGF drug ranibizumab for the treatment of diabetic macular edema (DME). Susvimo is designed as a long-acting, surgically implanted reservoir that continuously releases a customised formulation of ranibizumab, maintaining therapeutic drug levels for extended durations. Unlike traditional anti-VEGF intravitreal injections that often require monthly or bi-monthly dosing, Susvimo offers a refill-exchange interval of roughly six months, dramatically reducing patient treatment burden. Its sustained-delivery design enhances adherence, streamlines clinical workflow, and provides durable anatomical and visual benefits for patients with chronic retinal disease.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Macular Edema and Macular Degeneration Market?

In July 2024, Merck And Co. Inc., a US-based pharmaceutical and biotechnology company, acquired Eyebiotech Limited (Eyebio) for an undisclosed amount. The aim of the acquisition is to strengthen and diversify Merck's late-stage pipeline by adding Restoret, a novel late-phase candidate for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (NVAMD). This acquisition enhances MSD's portfolio with innovative treatments based on novel biology and genetics, addressing unmet medical needs in retinal diseases. Eyebiotech Limited (eyebio) is a US-based ophthalmology biotechnology company that develops therapies to treat sight-threatening eye diseases, including macular edema and macular degeneration.

Regional Outlook

North America was the largest region in the macular edema and macular degeneration market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Macular Edema and Macular Degeneration Market?

The macular edema and macular degeneration market consists of revenues earned by entities by providing services such as ophthalmic care, ophthalmologic evaluation, imaging and diagnostics, laser therapy, photodynamic therapy, and rehabilitation and low vision services. The market value includes the value of related goods sold by the service provider or included within the service offering. The macular edema and macular degeneration market also includes sales of surgical interventions, low vision aids, dietary supplements, retinal implants, and subretinal injections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Macular Edema and Macular Degeneration Market Report 2026?

The macular edema and macular degeneration market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the macular edema and macular degeneration industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Macular Edema and Macular Degeneration Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $11.03 billion
Revenue Forecast In 2035 $14.33 billion
Growth Rate CAGR of 6.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, AbbVie Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co Ltd, Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Kodiak Sciences Inc., Opthea Limited, IVERIC bio Inc., Neurotech Pharmaceuticals Inc., Regenxbio Inc., Graybug Vision Inc., Clearside Biomedical Inc., Kubota Pharmaceutical Holdings Co Ltd, Acucela Inc., PanOptica Inc., Ocugen Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Macular Edema and Macular Degeneration Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Macular Edema and Macular Degeneration Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Macular Edema and Macular Degeneration Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Macular Edema and Macular Degeneration Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Anti-Vegf Based Therapies

4.2.2 Growing Demand For Early Diagnosis And Intervention

4.2.3 Increasing Use Of Combination Drug And Laser Therapies

4.2.4 Rising Focus On Managing Diabetic Eye Complications

4.2.5 Expansion Of Outpatient And Clinic-Based Eye Care

5. Macular Edema and Macular Degeneration Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmic Clinics

5.3 Ambulatory Surgical Centers

5.4 Specialty Eye Care Centers

5.5 Other End Users

6. Macular Edema and Macular Degeneration Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Macular Edema and Macular Degeneration Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Macular Edema and Macular Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Macular Edema and Macular Degeneration Market Size, Comparisons And Growth Rate Analysis

7.3. Global Macular Edema and Macular Degeneration Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Macular Edema and Macular Degeneration Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Macular Edema and Macular Degeneration Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Macular Edema and Macular Degeneration Market Segmentation

9.1. Global Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Therapy, Laser Treatment

9.2. Global Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration

9.3. Global Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Other End Users

9.4. Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Combination Therapy (Anti-VEGF + Steroids)

9.5. Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Focal Laser Photocoagulation, Subthreshold Laser Therapy, MicroPulse Laser Therapy

10. Macular Edema and Macular Degeneration Market Regional And Country Analysis

10.1. Global Macular Edema and Macular Degeneration Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Macular Edema and Macular Degeneration Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Macular Edema and Macular Degeneration Market

11.1. Asia-Pacific Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Macular Edema and Macular Degeneration Market

12.1. China Macular Edema and Macular Degeneration Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Macular Edema and Macular Degeneration Market

13.1. India Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Macular Edema and Macular Degeneration Market

14.1. Japan Macular Edema and Macular Degeneration Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Macular Edema and Macular Degeneration Market

15.1. Australia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Macular Edema and Macular Degeneration Market

16.1. Indonesia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Macular Edema and Macular Degeneration Market

17.1. South Korea Macular Edema and Macular Degeneration Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Macular Edema and Macular Degeneration Market

18.1. Taiwan Macular Edema and Macular Degeneration Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Macular Edema and Macular Degeneration Market

19.1. South East Asia Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Macular Edema and Macular Degeneration Market

20.1. Western Europe Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Macular Edema and Macular Degeneration Market

21.1. UK Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Macular Edema and Macular Degeneration Market

22.1. Germany Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Macular Edema and Macular Degeneration Market

23.1. France Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Macular Edema and Macular Degeneration Market

24.1. Italy Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Macular Edema and Macular Degeneration Market

25.1. Spain Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Macular Edema and Macular Degeneration Market

26.1. Eastern Europe Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Macular Edema and Macular Degeneration Market

27.1. Russia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Macular Edema and Macular Degeneration Market

28.1. North America Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Macular Edema and Macular Degeneration Market

29.1. USA Macular Edema and Macular Degeneration Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Macular Edema and Macular Degeneration Market

30.1. Canada Macular Edema and Macular Degeneration Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Macular Edema and Macular Degeneration Market

31.1. South America Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Macular Edema and Macular Degeneration Market

32.1. Brazil Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Macular Edema and Macular Degeneration Market

33.1. Middle East Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Macular Edema and Macular Degeneration Market

34.1. Africa Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Macular Edema and Macular Degeneration Market Regulatory and Investment Landscape

36. Macular Edema and Macular Degeneration Market Competitive Landscape And Company Profiles

36.1. Macular Edema and Macular Degeneration Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Macular Edema and Macular Degeneration Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Macular Edema and Macular Degeneration Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Macular Edema and Macular Degeneration Market Other Major And Innovative Companies

Bausch Health Companies Inc., Santen Pharmaceutical Co Ltd, Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Kodiak Sciences Inc., Opthea Limited, IVERIC bio Inc., Neurotech Pharmaceuticals Inc., Regenxbio Inc., Graybug Vision Inc., Clearside Biomedical Inc., Kubota Pharmaceutical Holdings Co Ltd, Acucela Inc., PanOptica Inc., Ocugen Inc.

38. Global Macular Edema and Macular Degeneration Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Macular Edema and Macular Degeneration Market

40. Macular Edema and Macular Degeneration Market High Potential Countries, Segments and Strategies

40.1 Macular Edema and Macular Degeneration Market In 2030 - Countries Offering Most New Opportunities

40.2 Macular Edema and Macular Degeneration Market In 2030 - Segments Offering Most New Opportunities

40.3 Macular Edema and Macular Degeneration Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Macular Edema and Macular Degeneration Market, Overview Of Key Products - Product Examples
  • Table 2: Global Macular Edema and Macular Degeneration Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Macular Edema and Macular Degeneration Market, Supply Chain Analysis
  • Table 4: Global Macular Edema and Macular Degeneration Market, Major Raw Material Providers
  • Table 5: Global Macular Edema and Macular Degeneration Market, Major Resource Providers
  • Table 6: Global Macular Edema and Macular Degeneration Market, Major Manufacturers (Suppliers)
  • Table 7: Global Macular Edema and Macular Degeneration Market, Major Distributors And Channel Partners
  • Table 8: Global Macular Edema and Macular Degeneration Market, Key Technologies & Future Trends
  • Table 9: Global Macular Edema and Macular Degeneration Market, Major Trends
  • Table 10: Global Macular Edema and Macular Degeneration Market, Major End Users
  • Table 11: Global Macular Edema and Macular Degeneration Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Macular Edema and Macular Degeneration Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Macular Edema and Macular Degeneration Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Macular Edema and Macular Degeneration Market - TAM, US$ Billion, 2025
  • Table 15: Global Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Macular Edema and Macular Degeneration Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Macular Edema and Macular Degeneration Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Macular Edema and Macular Degeneration Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Macular Edema and Macular Degeneration Market - Company Scoring Matrix
  • Table 96: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 97: Novartis AG Financial Performance
  • Table 98: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 99: Bayer AG Financial Performance
  • Table 100: AbbVie Inc. Financial Performance
  • Table 101: Global Macular Edema and Macular Degeneration Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Macular Edema and Macular Degeneration Market, Competitive Dashboard
  • Table 103: Global Macular Edema and Macular Degeneration Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Macular Edema and Macular Degeneration Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 105: Global, Macular Edema and Macular Degeneration Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 106: Global, Macular Edema and Macular Degeneration Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Macular Edema and Macular Degeneration Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Macular Edema and Macular Degeneration Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Macular Edema and Macular Degeneration Market, Supply Chain Analysis
  • Figure 4: Global Macular Edema and Macular Degeneration Market, Major Raw Material Providers
  • Figure 5: Global Macular Edema and Macular Degeneration Market, Major Resource Providers
  • Figure 6: Global Macular Edema and Macular Degeneration Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Macular Edema and Macular Degeneration Market, Major Distributors And Channel Partners
  • Figure 8: Global Macular Edema and Macular Degeneration Market, Key Technologies & Future Trends
  • Figure 9: Global Macular Edema and Macular Degeneration Market, Major Trends
  • Figure 10: Global Macular Edema and Macular Degeneration Market, Major End Users
  • Figure 11: Global Macular Edema and Macular Degeneration Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Macular Edema and Macular Degeneration Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Macular Edema and Macular Degeneration Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Macular Edema and Macular Degeneration Market - TAM, US$ Billion, 2025
  • Figure 15: Global Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Macular Edema and Macular Degeneration Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Macular Edema and Macular Degeneration Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Macular Edema and Macular Degeneration Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Macular Edema and Macular Degeneration Market - Company Scoring Matrix
  • Figure 96: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 97: Novartis AG Financial Performance
  • Figure 98: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 99: Bayer AG Financial Performance
  • Figure 100: AbbVie Inc. Financial Performance
  • Figure 101: Global Macular Edema and Macular Degeneration Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Macular Edema and Macular Degeneration Market, Competitive Dashboard
  • Figure 103: Global Macular Edema and Macular Degeneration Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Macular Edema and Macular Degeneration Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 105: Global, Macular Edema and Macular Degeneration Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 106: Global, Macular Edema and Macular Degeneration Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Macular Edema and Macular Degeneration Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Ma...

Macular Degeneration Treatment Market Report 2026 - Global Outlook – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By Route of Administration (Oral, Injectable, Other Routes of Administration),...

Age-Related Macular Degeneration Market Report 2026 - Global Outlook – By Type (Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)), By Drug (Eylea, Lucentis, Avastin, Other Drugs), By...

Anemia And Other Blood Disorder Drugs Market Report 2026 - Global Outlook – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia ), By Route of Administration (Oral, Injecta...

Ocular Inflammation Treatment Market Report 2026 - Global Outlook – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode Of Operation (Injectables, O...

Retinal Disorder Treatment Market Report 2026 - Global Outlook – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Dis...

Ocular Hypertension Treatment Market Report 2026 - Global Outlook – By Type (Intraocular Hypertension, Glaucoma), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Ho...

Non-Proliferative Diabetic Retinopathy Market Report 2026 - Global Outlook – By Treatment Type (Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Diseas...

Frequently Asked Questions

The Macular Edema and Macular Degeneration market was valued at $10.33 billion in 2025, increased to $11.03 billion in 2026, and is projected to reach $14.33 billion by 2030.

The global Macular Edema and Macular Degeneration market is expected to grow at a CAGR of 6.8% from 2026 to 2035 to reach $14.33 billion by 2035.

Some Key Players in the Macular Edema and Macular Degeneration market Include, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, AbbVie Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co Ltd, Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Kodiak Sciences Inc., Opthea Limited, IVERIC bio Inc., Neurotech Pharmaceuticals Inc., Regenxbio Inc., Graybug Vision Inc., Clearside Biomedical Inc., Kubota Pharmaceutical Holdings Co Ltd, Acucela Inc., PanOptica Inc., Ocugen Inc. .

Major trend in this market includes: Next-Generation Solutions for Chronic Eye Conditions Transforming Standard Care Practices. For further insights on this market. request a sample here

North America was the largest region in the macular edema and macular degeneration market in 2025. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us